Policy Levers
2015 - 2030 ODE
Annual Screening Rate
18.0%
Case-finding velocity across high-risk & primary care.
DAA Treatment Velocity
85.0%
Rate of linking diagnosed chronic cases to curative DAA.
Harm Reduction Saturation
75.0%
OAT and high-coverage needle exchange distribution.
Reinfection Risk Friction
4.0%
Annual transmission risk post-cure in high-risk pools.
Epidemic Trajectory & Projections
Status: On Track for 2026
2026 Chronic Cases
18,420
-73.7% vs 2015
Annual Incidences
420
-88.2% vs 2015
Cumulative Cures
62,800
Direct Antivirals
WHO Target Verification
2030 Mandate
1. Diagnosis (90% Target)
92.0% Achieved
2. Treatment (80% Target)
88.0% Achieved
3. Mortality Reduction (65%)
68.0% Achieved
Executive Summary
Generating summary report...